| CX3CL1 is neuroprotective in permanent focal cerebral ischemia in rodents R Cipriani, P Villa, G Chece, C Lauro, A Paladini, E Micotti, C Perego, ... Journal of Neuroscience 31 (45), 16327-16335, 2011 | 195 | 2011 |
| KCa3. 1 channels are involved in the infiltrative behavior of glioblastoma in vivo G D'Alessandro, M Catalano, M Sciaccaluga, G Chece, R Cipriani, ... Cell death & disease 4 (8), e773-e773, 2013 | 129 | 2013 |
| Anomalous levels of Cl− transporters cause a decrease of GABAergic inhibition in human peritumoral epileptic cortex L Conti, E Palma, C Roseti, C Lauro, R Cipriani, M de Groot, E Aronica, ... Epilepsia 52 (9), 1635-1644, 2011 | 119 | 2011 |
| Activity of adenosine receptors type 1 is required for CX3CL1-mediated neuroprotection and neuromodulation in hippocampal neurons C Lauro, S Di Angelantonio, R Cipriani, F Sobrero, L Antonilli, V Brusadin, ... The Journal of Immunology 180 (11), 7590-7596, 2008 | 118 | 2008 |
| FTY720 attenuates excitotoxicity and neuroinflammation R Cipriani, JC Chara, A Rodríguez-Antigüedad, C Matute Journal of neuroinflammation 12, 1-14, 2015 | 108 | 2015 |
| Adenosine A1 receptors and microglial cells mediate CX3CL1-induced protection of hippocampal neurons against Glu-induced death C Lauro, R Cipriani, M Catalano, F Trettel, G Chece, V Brusadin, ... Neuropsychopharmacology 35 (7), 1550-1559, 2010 | 108 | 2010 |
| CX3CL1 protects neurons against excitotoxicity enhancing GLT-1 activity on astrocytes M Catalano, C Lauro, R Cipriani, G Chece, A Ponzetta, S Di Angelantonio, ... Journal of neuroimmunology 263 (1-2), 75-82, 2013 | 48 | 2013 |
| Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination A Manterola, A Bernal-Chico, R Cipriani, M Canedo-Antelo, ... Biochemical pharmacology 157, 189-201, 2018 | 37 | 2018 |
| Sorcin is an early marker of neurodegeneration, Ca2+ dysregulation and endoplasmic reticulum stress associated to neurodegenerative diseases I Genovese, F Giamogante, L Barazzuol, T Battista, A Fiorillo, M Vicario, ... Cell Death & Disease 11 (10), 861, 2020 | 31 | 2020 |
| Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitis A Manterola, A Bernal-Chico, R Cipriani, A Ruiz, A Perez-Samartin, ... Neuropharmacology 141, 181-191, 2018 | 21 | 2018 |
| P2x7 receptors control demyelination and inflammation in the cuprizone model A Bernal-Chico, A Manterola, R Cipriani, I Katona, C Matute, S Mato Brain, Behavior, & Immunity-Health 4, 100062, 2020 | 18 | 2020 |
| Effects of FTY720 on brain neurogenic niches in vitro and after kainic acid-induced injury R Cipriani, JC Chara, A Rodríguez-Antigüedad, C Matute Journal of Neuroinflammation 14, 1-13, 2017 | 13 | 2017 |
| Chemokine CXCL8 modulates GluR1 phosphorylation M Catalano, F Trettel, R Cipriani, C Lauro, F Sobrero, F Eusebi, ... Journal of neuroimmunology 198 (1-2), 75-81, 2008 | 11 | 2008 |
| KCa3. 1 channels are involved in the infiltrative behavior of glioblastoma in vivo. Cell Death Dis. 2013; 4: e773 G D’Alessandro, M Catalano, M Sciaccaluga, G Chece, R Cipriani, ... | 6 | |
| New, fully implantable device for selective clearance of csf-target molecules: proof of concept in a murine model of Alzheimer’s disease MA Coto-Vilcapoma, J Castilla-Silgado, B Fernández-García, ... International journal of molecular sciences 23 (16), 9256, 2022 | 5 | 2022 |
| Ischemia and stroke R Cipriani, M Domercq, C Matute Microglia in Health and Disease, 413-435, 2014 | 4 | 2014 |
| Characterization of molecular biomarkers in cerebrospinal fluid and serum of E46K-SNCA mutation carriers A Murueta-Goyena, R Cipriani, M Carmona-Abellán, M Acera, N Ayo, ... Parkinsonism & Related Disorders 96, 29-35, 2022 | 2 | 2022 |
| Assessment of the Correlation and Diagnostic Accuracy between CSF and Plasma AD Biomarkers: A Comparison of the Lumipulse and Simoa Platforms F Dakterzada, R Cipriani, R López-Ortega, A Arias, I Riba-Llena, ... | | 2024 |
| Neurofilament light chain serum levels in E46K-SNCA mutation carriers A Murueta-Goyena, MA Acera, N Ayo, M Carmona-Abellan, R Del Pino, ... MOVEMENT DISORDERS 36, S340-S340, 2021 | | 2021 |
| GABA (B) receptor downstream mechanisms in OPCs and its role in myelination and remyelination L Bayon-Cordero, BI Ochoa-Bueno, MP Serrano-Regal, V Tepavcevic, ... GLIA 69, E540-E541, 2021 | | 2021 |
Cristina LimatolasapienzaVerified email at uniroma1.it
